Author Question: The atherogenic effect of homocysteine is: A. The toxic effect on the left ventricular wall of ... (Read 82 times)

mcmcdaniel

  • Hero Member
  • *****
  • Posts: 550
The atherogenic effect of homocysteine is:
 
  A. The toxic effect on the left ventricular wall of the heart.
  B. The toxic effect of homocysteine on the adventitia or outer lining the arterial wall.
  C. The toxic effect of homocysteine on the endothelial lining of the arteries, which causes plaque formation.
  D. Nontoxic effect of homocysteine on the intima lining of the arteries.

Question 2

Which of the following is a useful clinical laboratory test for bile salt malabsorption?
 
  A. Measurement of 1, 25-dihydroxycholecalciferol
  B. Measurement of 7-hydroxy-4-cholesten-3-one
  C. Measurement of cholesterol
  D. Measurement of cytotoxin-associated gene A (CagA)


amandalm

  • Sr. Member
  • ****
  • Posts: 306
Answer to Question 1

C

Answer to Question 2

B



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

In 1886, William Bates reported on the discovery of a substance produced by the adrenal gland that turned out to be epinephrine (adrenaline). In 1904, this drug was first artificially synthesized by Friedrich Stolz.

Did you know?

On average, someone in the United States has a stroke about every 40 seconds. This is about 795,000 people per year.

Did you know?

In 1835 it was discovered that a disease of silkworms known as muscardine could be transferred from one silkworm to another, and was caused by a fungus.

Did you know?

About 60% of newborn infants in the United States are jaundiced; that is, they look yellow. Kernicterus is a form of brain damage caused by excessive jaundice. When babies begin to be affected by excessive jaundice and begin to have brain damage, they become excessively lethargic.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library